Leukocyte Surface Antigen CD47 Market Overview
The Leukocyte Surface Antigen CD47 Market was valued at USD 496.5 million in 2024 and is projected to reach USD 1,500 million by 2035, growing at a CAGR of 10.6%. CD47, also known as the "don't eat me" signal, is a transmembrane protein overexpressed on cancer cells that enables immune evasion by binding to SIRPα on macrophages. The market is segmented by product type into Antibodies,...
0 Comments 0 Shares 81 Views 0 Reviews